Stay updated on ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page footer revision label was updated from v3.5.4 to v3.5.5, indicating a newer version of the page rendering.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe study's revision history now shows Revision: v3.5.4 replacing Revision: v3.5.3, indicating an administrative update to the record. This change does not alter the study data, eligibility, or results.SummaryDifference0.0%

- Check40 days agoChange DetectedThe Record History now shows a new version tag (Revision: v3.5.3) replacing the previous v3.5.2. This indicates an update to the page history metadata rather than changes to the study content.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the page history.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 in the page footer.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision v3.4.3 was added to the history and revision v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page.